Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE:532488

₹4571.45 -30.65 (-0.67%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

4565.20

Today’s High

4620.80

52W low

3295.30

52W High

4648.40

Open Price

4607.70

Prev. Close

4448.9000

Volume

262203.00

Value

1198647904.35

Fundamentals

Market Cap Cr

121357.60

Price to Earnings

75.80

Price to Book Value

8.90

Dividend Yield

0.70

PE to Growth

-6.20

Op Revenue TTM Cr

7845.00

Net Profit TTM Cr

1600.00

Cash From Operating Activity Cr

1261.00

Return on Equity %

11.78

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

4569.4

10Day EMA

4549

12Day EMA

4538.8

20Day EMA

4484.9

26Day EMA

4437.4

50Day EMA

4263.9

100Day EMA

4053.8

200Day EMA

3870.9

5Day SMA

4567.5

10Day SMA

4540.2

20Day SMA

4520.6

30Day SMA

4428.7

50Day SMA

4216.1

100Day SMA

3912.9

150Day SMA

3864.4

200Day SMA

3804

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

02 Jul, 2024

63.1

Week

58.7

Month

52.1

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

4585.85

PIVOT

First Resistance

4606.45

Second Resistance

4641.45

Third Resistance

4662.05

First Support

4550.85

Second Support

4530.25

Third Support

4495.25

Relative Strength Index

63.41

Money Flow Index

58.44

MACD

101.42

MACD Signal

116.98

Average True Range

98.5

Average Directional Index

27.69

Rate of Change (21)

6.14

Rate of Change (125)

17.1

Commodity Channel Index

96.4

Williams %R

-35.9

BETA

1 Month

0.26

3 Month

0.29

1 Year

0.45

3 Year

0.12

PRICE CHANGE ANALYSIS

↑ 1.15%

1 Week

Low

High

4488.05

4648.45

↑ 6.14%

1 Month

Low

High

4180.5

4648.45

↑ 28.13%

3 Months

Low

High

3555.2

4648.45

↑ 16.74%

6 Months

Low

High

3350

4648.45

↑ 27.57%

1 Year

Low

High

3295.3

4648.45

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 2338.00 1902.00 1953.00 1810.00 1974.32 1806.17 1902.63 2293.91 2545.54 2483.39 1986.97
Operating Expenses Qtr 1542.00 1317.00 1394.00 1239.00 1419.47 1280.41 1214.12 1366.34 1399.06 1366.87 1149.27
Operating Profit Qtr 717.00 491.00 474.00 491.00 488.70 409.42 609.26 837.58 1095.97 1099.90 818.59
EBIDT Qtr Cr 796.00 585.00 559.00 571.00 554.85 525.76 688.51 927.57 1146.48 1116.52 837.70
Depreciation Qtr 94.00 95.00 94.00 93.00 86.63 86.54 85.48 83.42 80.75 79.70 77.09
Net Profit Qtr 531.00 358.00 342.00 345.00 318.79 310.90 486.85 691.61 882.96 907.22 606.39
Basic EPS Qtr 19.99 13.50 12.89 12.99 12.01 11.71 18.34 26.05 33.26 34.17 22.84
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 8002.00 7974.31 8991.08 6861.14 5500.43
Operating Expenses Annual Cr 5491.00 5277.62 5003.36 3977.93 3495.13
Operating Profit Annual 2174.00 2347.68 3876.46 2820.68 1815.44
Operating Profit Margin Annual % 27.17 29.44 43.11 41.11 33.01
Total Expenses Annual Cr 5870.00 5620.21 5314.56 4233.27 3687.14
EBIDT Annual Cr 2511.00 2696.69 3987.72 2883.21 2005.30
EBIDT Annual margin % 31.38 33.82 44.35 42.02 36.46
Depreciation 376.00 342.07 310.55 254.65 185.95
PAT Before ExtraOrdinary Items Annual Cr 1576.00 1808.15 2948.54 1954.72 1372.71
Net Profit Annual 1576.00 1808.15 2948.54 1954.72 1372.71
Basic EPS Annual 59.37 68.11 111.07 73.63 51.71
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 13484.00 12705.42 11691.35 9271.57 7316.69
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 619.00 567.83 448.11 363.31 294.48
Total Current Liabilities Annual Cr 1259.00 1078.37 1168.40 1088.89 902.94
Total Capital Plus Liabilities Annual Cr 15362.00 14351.62 13307.86 10723.77 8514.11
Fixed Assets Annual 5515.00 4930.64 4790.90 4409.63 3695.95
Total Non Current Assets Annual 5790.00 5116.17 5011.90 4598.46 3852.94
Total Current Assets Annual 9572.00 9235.45 8295.96 6125.31 4661.17
Total Assets Annual 15362.00 14351.62 13307.86 10723.77 8514.11
Contingent Liabilities plus Commitments Annual Cr - 736.98 1259.90 1107.13 1223.83
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 1266.00 2447.95 1910.16 1947.05 1208.47
Cash from Investing Activity Annual -268.00 -2706.75 -2195.40 75.34 -81.38
Cash from Financing Annual Activity -798.00 -796.59 -531.50 -33.97 -1091.25
Net Cash Flow Annual - -1055.39 -816.74 1988.42 35.84
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 508.83 478.64 440.44 349.28 275.63
ROE Annual % 11.68 14.23 25.21 21.08 18.76
ROCE Annual % 15.13 17.73 30.29 27.28 23.90
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 32.75 35.36 44.90 42.40 37.76
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 2382.00 1950.00 1995.00 1859.00 2016.92 1821.93 1934.62 2342.91 2570.83 2509.86 2006.62
Operating Expenses Qtr 1572.00 1366.00 1430.00 1274.00 1463.18 1299.40 1233.50 1407.82 1414.01 1396.06 1169.44
Operating Profit Qtr 731.00 489.00 479.00 504.00 487.59 408.28 621.04 846.70 1104.43 1097.18 818.07
EBIDT Qtr Cr 810.00 584.00 565.00 585.00 553.74 522.53 701.12 935.09 1156.82 1113.80 837.18
Depreciation Qtr 95.00 95.00 95.00 93.00 87.02 86.77 85.73 83.66 80.99 79.91 77.35
Net Profit Qtr 538.00 358.00 348.00 356.00 320.97 306.80 493.60 702.01 894.64 902.24 606.46
Basic EPS Qtr 20.25 13.50 13.11 13.41 12.09 11.56 18.60 26.44 33.70 33.99 22.84
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 8184.00 8112.17 9073.70 7031.96 5584.05
Operating Expenses Annual Cr 5640.00 5399.69 5077.89 4109.46 3572.25
Operating Profit Annual 2205.00 2367.82 3881.94 2859.94 1822.17
Operating Profit Margin Annual % 26.94 29.19 42.78 40.67 32.63
Total Expenses Annual Cr 6021.00 5743.54 5390.20 4365.92 3764.59
EBIDT Annual Cr 2544.00 2712.48 3995.81 2922.50 2011.80
EBIDT Annual margin % 31.09 33.44 44.04 41.56 36.03
Depreciation 378.00 343.18 311.51 255.59 186.24
PAT Before ExtraOrdinary Items Annual Cr 1600.00 1823.38 2960.45 1984.29 1376.54
Net Profit Annual 1600.00 1823.38 2960.45 1984.29 1376.54
Basic EPS Annual 60.27 68.69 111.52 74.75 51.85
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 13571.00 12767.09 11728.18 9294.61 7309.92
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 621.00 570.60 450.98 367.00 298.95
Total Current Liabilities Annual Cr 1278.00 1101.08 1195.55 1112.46 926.83
Total Capital Plus Liabilities Annual Cr 15470.00 14438.77 13374.71 10774.07 8535.70
Fixed Assets Annual 5517.00 4934.48 4794.98 4414.49 3701.54
Total Non Current Assets Annual 5795.00 5127.03 5023.21 4599.36 3855.87
Total Current Assets Annual 9675.00 9311.74 8351.50 6174.71 4679.83
Total Assets Annual 15470.00 14438.77 13374.71 10774.07 8535.70
Contingent Liabilities plus Commitments Annual Cr - 736.98 1259.90 1107.13 1222.84
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 1261.00 2459.73 1911.80 1946.93 1215.94
Cash from Investing Activity Annual -269.00 -2707.62 -2194.92 75.13 -83.47
Cash from Financing Annual Activity -799.00 -797.17 -532.44 -34.89 -1091.42
Net Cash Flow Annual - -1045.06 -815.56 1987.17 41.05
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 512.11 480.96 441.82 350.15 275.38
ROE Annual % 11.78 14.28 25.24 21.34 18.83
ROCE Annual % 15.26 17.76 30.25 27.60 23.99
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 32.42 34.92 44.59 41.93 37.29
Name Holding Percent Holding Id Pledged % Locked %
SBI MUTUAL FUND 7.85 80272068 - -
AXIS MUTUAL FUND TRUSTEE LIMITED 1.69 80272069 - -
GOVERNMENT PENSION FUND GLOBAL 1.23 80272077 - -
Name Holding Percent Holding Id Pledged % Locked %
NILIMA PRASAD DIVI 20.34 80272058 0 0
SATCHANDRA KIRAN DIVI 20.34 80272059 0 0
SWARNA LATHA DIVI 5.27 80272060 0 0
MURALI KRISHNA PRASAD DIVI 2.85 80272061 0 0
DIVI'S BIOTECH PRIVATE LIMITED 3.01 80272065 0 0
Name Holding Percent Holding Id
SBI MUTUAL FUND 7.85 80272068
AXIS MUTUAL FUND TRUSTEE LIMITED 1.69 80272069
GOVERNMENT PENSION FUND GLOBAL 1.23 80272077
LIFE INSURANCE CORPORATION OF INDIA 6.09 80272071
Name Holding Percent Holding Id
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Aug 11, 2023 30 FINAL Aug 11, 2023 Equity Share
Aug 11, 2022 30 FINAL Aug 12, 2022 Equity Share
Aug 17, 2021 20 FINAL - Equity Share
Feb 25, 2020 16 INTERIM Feb 26, 2020 Equity Share
Aug 14, 2019 16 FINAL - Equity Share
Aug 31, 2018 10 FINAL - Equity Share
Sep 15, 2017 10 FINAL - Equity Share
Mar 17, 2016 10 INTERIM Mar 18, 2016 Equity Share
Aug 06, 2015 20 FINAL - Equity Share
Jul 31, 2014 20 FINAL - Equity Share
Jul 25, 2013 15 FINAL - Equity Share
Jul 26, 2012 13 FINAL - Equity Share
Jun 16, 2011 10 FINAL - Equity Share
Jul 02, 2010 6 FINAL - Equity Share
Jun 15, 2009 6 FINAL - Equity Share
Jun 26, 2008 4 FINAL - Equity Share
Mar 23, 2007 10 INTERIM Mar 26, 2007 Equity Share
Aug 23, 2006 10 FINAL - Equity Share
Aug 11, 2005 8 FINAL - Equity Share
Jul 29, 2004 8 FINAL - Equity Share
Aug 11, 2003 6 FINAL - Equity Share
Ex-Date Split Ratio Record Date
Aug 03, 2007 10:2 -
Ex-Date Purpose Notes
May 25, 2024 Audited Results & Dividend -
Feb 10, 2024 Quarterly Results -
Nov 06, 2023 Quarterly Results -
Aug 14, 2023 Quarterly Results -
May 20, 2023 Audited Results & Final Dividend -
Feb 03, 2023 Quarterly Results -
Nov 07, 2022 Quarterly Results -
Aug 12, 2022 Quarterly Results -
May 23, 2022 Audited Results & Dividend -
Feb 11, 2022 Quarterly Results (Revised)
Nov 06, 2021 Quarterly Results -
Aug 07, 2021 Quarterly Results -
May 29, 2021 Audited Results & Final Dividend -
Feb 06, 2021 Quarterly Results -
Nov 07, 2020 Quarterly Results -
Aug 08, 2020 Quarterly Results -
Jun 06, 2020 Audited Results -
Feb 12, 2020 Interim Dividend -
Feb 05, 2020 Quarterly Results -
Nov 05, 2019 Quarterly Results -
Aug 10, 2019 Quarterly Results -
May 25, 2019 Audited Results & Final Dividend -
Feb 02, 2019 Quarterly Results -
Oct 27, 2018 Quarterly Results -
Aug 04, 2018 Quarterly Results -
May 26, 2018 Audited Results & Dividend -
Jan 27, 2018 Quarterly Results -
Oct 31, 2017 Quarterly Results -
Jul 22, 2017 Quarterly Results -
Jun 28, 2017 Others 1. Appointed Dr. Ramesh B. V. Nimmagadda as an Additional (Independent) Director w.e.f. 27th June, 2017. 2. Appointed Ms. Nilima Motaparti, as an Additional (Whole-time) Director w.e.f. 27th June,2017
May 26, 2017 Audited Results & Dividend -
Feb 04, 2017 Quarterly Results -
Nov 12, 2016 Quarterly Results -
Aug 12, 2016 Quarterly Results -
May 28, 2016 Audited Results & Final Dividend Interalia, has recommended the interim dividend declared as final dividend for the year ended March 31, 2016.
Mar 10, 2016 Interim Dividend -
Feb 05, 2016 Quarterly Results Approved to shift the Registered Office of the Company.
Oct 31, 2015 Quarterly Results -
Aug 08, 2015 Quarterly Results -
May 23, 2015 Audited Results & Dividend -
Jan 31, 2015 Quarterly Results -
Nov 01, 2014 Quarterly Results -
Aug 11, 2014 Quarterly Results -
May 24, 2014 Audited Results & Dividend -
Feb 03, 2014 Quarterly Results -
Nov 08, 2013 Quarterly Results -
Aug 03, 2013 Quarterly Results -
May 20, 2013 Audited Results & Dividend -
Feb 02, 2013 Quarterly Results -
Nov 03, 2012 Quarterly Results -
Aug 04, 2012 Quarterly Results -
May 12, 2012 Audited Results & Dividend -
Jan 28, 2012 Quarterly Results -
Nov 01, 2011 Quarterly Results -
Aug 06, 2011 Quarterly Results -
May 20, 2011 Audited Results & Dividend -
Feb 04, 2011 Quarterly Results -
Nov 09, 2010 Quarterly Results -
Aug 12, 2010 Quarterly Results -
May 22, 2010 Audited Results & Dividend -
Jan 29, 2010 Quarterly Results -
Oct 30, 2009 Quarterly Results -
Jul 31, 2009 Quarterly Results -
Jun 06, 2009 Audited Results, Dividend & Bonus To recommend a issue of bonus shares in the ratio of one share for every share held, subject to approval of members.
Apr 14, 2009 Others To seek shareholders approval by postal ballot for re-appointment of Mr. Madhusudana Rao Divi as Director (Projects) of the Co. & re-appointment of Mr. Kiran S Divi as Director of the Co.
Jan 24, 2009 Quarterly Results -
Oct 29, 2008 Quarterly Results -
Jul 26, 2008 Quarterly Results -
Jun 07, 2008 Audited Results & Dividend (Revised)
Jan 28, 2008 Quarterly Results -
Oct 27, 2007 Quarterly Results -
Jul 30, 2007 Quarterly Results -
May 23, 2007 Audited Results & Stock Split -
Mar 17, 2007 Interim Dividend -
Jan 27, 2007 Quarterly Results -
Oct 28, 2006 Quarterly Results -
Jul 31, 2006 Quarterly Results -
Jun 17, 2006 Accounts & Dividend -
Jan 30, 2006 Quarterly Results & ESOP -
Oct 28, 2005 Quarterly Results -
Jul 29, 2005 Quarterly Results -
May 21, 2005 Accounts & Dividend -
Jan 28, 2005 Quarterly Results & Others To consider the increasing of the limits of shareholding of Foreign Institutional Investors in the company.
Oct 21, 2004 Quarterly Results (Revised)
Jul 28, 2004 Quarterly Results -
May 17, 2004 Dividend & Accounts -
Jan 27, 2004 Quarterly Results -
Oct 24, 2003 Quarterly Results -
Jul 30, 2003 Quarterly Results -
May 22, 2003 Dividend & Accounts -
Ex-Date Bonus Ratio Record Date
Sep 23, 2015 1:1 2015-09-26
Jul 30, 2009 1:1 2009-08-01
Bigul
29 Jun 2024

DIVI'S LABORATORIES LTD. - 532488 - Closure of Trading Window

 Intimation of Trading Window closure from July 01, 2024 till 48 hours after the declaration of unaudited financial results of the Company for the quarter ending June 30, 2024.
Bigul
22 Jun 2024

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Cessation

 Intimation of completion of tenure of Mr. K.V. K. Seshavataram as Independent Director of the Company w.e.f. 22.06.2024.
Bigul
22 Jun 2024

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Cessation

 Intimation of completion of tenure of Mr. K.V.K. Seshavataram as Independent Director of the Company on June 22, 2024.
Bigul
20 Jun 2024

DIVI'S LABORATORIES LTD. - 532488 - Communication To Shareholders - Information Regarding Deduction Of Income Tax At Source From Payment Of Dividend For The Financial Year 2023-24

 As per enclsoed letter.
Bigul
30 May 2024

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Transcript of Q4FY24 earnings call held on May 25, 2024.
Bigul
27 May 2024

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Copies of Newspaper Publication regarding extracts of Audited Financial Results of the Company for the quarter and year ended March 31, 2024.
Bigul
25 May 2024

DIVI'S LABORATORIES LTD. - 532488 - Compliance Of Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 As per enclosed letter.
25 May 2024

Divi's Laboratories Results Earnings Call for Q4FY24

 Conference Call with Divi's Laboratories Ltd. Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.
Bigul
25 May 2024

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Submission of weblink of Audio recording of earnings conference call Q4FY2024 held on May 25, 2024.
Bigul
25 May 2024

DIVI'S LABORATORIES LTD. - 532488 - Corporate Action-Board approves Dividend

 As per enclosed letter.
See all News

FAQs

The latest market price of Divi's Laboratories Ltd. on NSE was Rs. 4571.45 as of today.

The opening share price of Divi's Laboratories Ltd. was Rs. 4607.70 as of today.

The 52-week high share price of Divi's Laboratories Ltd. was Rs. 4648.40.

The 52 week low share price of Divi's Laboratories Ltd. was Rs. 3295.30.

Divi's Laboratories Ltd. has a market cap of Rs. 121357.60 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Divi's Laboratories Ltd. is -6.20. Please refer to the Fundamentals section for further details.

The operating revenue for Divi's Laboratories Ltd. in the last FY was Rs.  7845.00 crore. Please refer to the Financials section for further details.

The Net Profit for Divi's Laboratories Ltd. in the last FY was Rs. 1600.00 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Divi's Laboratories Ltd. was on 2023-08-11 for Rs. 30 per share. According to today’s share price, the dividend yield of Divi's Laboratories Ltd. stands at 0.70. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Divi's Laboratories Ltd. was as of 2015-09-23. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Divi's Laboratories Ltd. was as of 2007-08-03. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Divi's Laboratories Ltd..

Close

Let's Open Free Demat Account